1-1 of 1
Greg O'Connor, MS
Close
Save search
Sort by
Journal Articles

Development and Use of Clinical Pharmacodynamic Assays to Demonstrate Target Engagement for AZD4573, a Selective and Potent CDK9 Inhibitor Currently in Phase I Clinical Trials

Free
Tammie Yeh, PhD, Greg O'Connor, MS, Justin Cidado, PhD, J. Carl Barrett, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3505.
https://doi.org/10.1182/blood-2018-99-114948
Published: 2018